Published in J Nucl Med on July 01, 1990
Dynamic single photon emission computed tomography--basic principles and cardiac applications. Phys Med Biol (2010) 1.24
Compartmental modeling of technetium-99m-labeled teboroxime with dynamic single-photon emission computed tomography: comparison with static thallium-201 in a canine model. Invest Radiol (2001) 1.07
Static Versus Dynamic Teboroxime Myocardial Perfusion SPECT in Canines. IEEE Trans Nucl Sci (2000) 0.88
4D maximum a posteriori reconstruction in dynamic SPECT using a compartmental model-based prior. Phys Med Biol (2001) 0.83
SPECT Imaging of Teboroxime during Myocardial Blood Flow Changes. IEEE Trans Nucl Sci (2000) 0.80
Myocardial clearance of technetium-99m-teboroxime in reperfused injured canine myocardium. EJNMMI Res (2014) 0.75
The sequence of the human genome. Science (2001) 101.55
Spatial resolution properties of penalized-likelihood image reconstruction: space-invariant tomographs. IEEE Trans Image Process (1996) 4.41
Dynamic visualization of local protein synthesis in hippocampal neurons. Neuron (2001) 4.14
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med (2001) 3.39
Reproducibility of metabolic measurements in malignant tumors using FDG PET. J Nucl Med (1999) 3.20
Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res (2001) 3.01
Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol (2001) 2.91
Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. J Clin Oncol (1993) 2.79
Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol (1994) 2.78
Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med (1986) 2.63
Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol (2000) 2.58
Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol (2000) 2.28
Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med (1991) 2.18
Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol (1992) 2.18
Evaluation of the novel myocardial perfusion positron-emission tomography tracer 18F-BMS-747158-02: comparison to 13N-ammonia and validation with microspheres in a pig model. Circulation (2009) 2.15
Informatics and medicine--from molecules to populations. Methods Inf Med (2008) 2.13
Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med (2001) 2.12
Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med (1999) 2.11
Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol (1990) 2.07
Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function. Circulation (1997) 2.05
Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg (2001) 2.04
Myocardial contractility in a canine model of the brain-dead organ donor. Crit Care Med (1993) 2.03
Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J Nucl Med (2001) 2.00
Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease. Neurology (2009) 1.99
Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo. Virology (2000) 1.98
Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med (1995) 1.95
Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody. N Engl J Med (1993) 1.95
Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol (1999) 1.86
Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem (2000) 1.86
SEPP: SATé-enabled phylogenetic placement. Pac Symp Biocomput (2012) 1.84
Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain (2001) 1.83
Myocardial protection with preconditioning. Circulation (1990) 1.83
Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology (1991) 1.80
Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation (1990) 1.78
Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. J Am Coll Cardiol (1990) 1.73
The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow. J Am Coll Cardiol (1992) 1.68
Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol (1997) 1.68
Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med (1999) 1.63
Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med (1997) 1.61
Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion. Proc Natl Acad Sci U S A (2009) 1.60
Spontaneous thrombosis in mice carrying the factor V Leiden mutation. Blood (2000) 1.58
Narrow-band imaging in the evaluation of villous morphology: a feasibility study assessing a simplified classification and observer agreement. Endoscopy (2010) 1.55
Patients' requests and satisfaction with services in an outpatient psychiatric setting. Psychiatr Serv (1996) 1.53
Correlation methods for the centering, rotation, and alignment of functional brain images. J Nucl Med (1990) 1.52
Advantages of short-lived positron-emitting radioisotopes for intracoronary radiation therapy with liquid-filled balloons to prevent restenosis. J Nucl Med (2001) 1.52
Regional myocardial blood flow and metabolism at rest in mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (1989) 1.51
O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med (2000) 1.48
Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. J Am Coll Cardiol (1991) 1.48
Relationship between altered sympathetic innervation, oxidative metabolism and contractile function in the cardiomyopathic human heart; a non-invasive study using positron emission tomography. Eur Heart J (2001) 1.47
The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging (2007) 1.46
Metaiodobenzylguanidine scintigraphy of the heart: what have we learnt clinically? Eur J Nucl Med (2000) 1.45
Region-specific encoding of sensory and affective components of pain in the human brain: a positron emission tomography correlation analysis. Ann Neurol (1999) 1.43
Myocardial revascularization of the canine circumflex coronary artery using retrograde internal mammary artery flow without cardiopulmonary bypass. Ann Thorac Surg (1981) 1.43
Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation (2000) 1.42
Focal metabolic activation in the predominant left auditory cortex in patients suffering from tinnitus: a PET study with [18F]deoxyglucose. ORL J Otorhinolaryngol Relat Spec (1997) 1.42
The concentration of calcium in neonatal cardioplegia. Ann Thorac Surg (1990) 1.42
Determination of extent and location of coronary artery disease in patients without prior myocardial infarction by thallium-201 tomography with pharmacologic stress. J Nucl Med (1992) 1.41
Determination of coronary flow reserve by parametric imaging. Circulation (1990) 1.41
Comparison of technetium-99m sestamibi and thallium-201 retention characteristics in canine myocardium. J Am Coll Cardiol (1992) 1.41
Technetium-99m-N1-(2-mercapto-2-methylpropyl)-N2-(2-propargylthio-2- methylpropyl)-1,2-benzenediamine (T691): preclinical studies of a potential new tracer of regional cerebral perfusion. J Nucl Med (1992) 1.40
An automated analysis program for the evaluation of cardiac PET studies: initial results in the detection and localization of coronary artery disease using nitrogen-13-ammonia. J Nucl Med (1993) 1.39
Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study. Neurobiol Aging (2006) 1.39
Vietnamese diabetic patients and their physicians: what ethnography can teach us. West J Med (2001) 1.38
Early recovery of coronary flow reserve after stent implantation as assessed by positron emission tomography. J Am Coll Cardiol (1999) 1.38
Characterization of translocation contact sites involved in the import of mitochondrial proteins. J Cell Biol (1987) 1.37
Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med (1993) 1.36
IL-4 is protective against development of toxoplasmic encephalitis. J Immunol (1996) 1.34
Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology (2005) 1.33
Radiolabelled RGD peptides for imaging and therapy. Eur J Nucl Med Mol Imaging (2012) 1.33
A randomized trial of late reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction-6 Study Group. Circulation (1992) 1.32
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood (1998) 1.32
Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med (1981) 1.31
Nonuniformity of inner and outer systolic wall thickening in conscious dogs. Am J Physiol (1985) 1.31
Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med (1989) 1.30
Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation (1998) 1.29
Carbon-11-acetate PET imaging in renal disease. J Nucl Med (1995) 1.28
Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene (2001) 1.26
Differential diagnosis of CNS lesions in AIDS patients by FDG-PET. J Comput Assist Tomogr (1995) 1.26
Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression. Nuklearmedizin (2004) 1.25
Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel. Cancer Res (2001) 1.24
Uptake of radiolabeled 2'-fluoro-2'-deoxy-5-iodo-1-beta-D-arabinofuranosyluracil in cardiac cells after adenoviral transfer of the herpesvirus thymidine kinase gene: the cellular basis for cardiac gene imaging. Circulation (2000) 1.22
Inter-crystal scatter in a dual layer, high resolution LSO-APD positron emission tomograph. Phys Med Biol (2003) 1.22
Direct measurement of inner and outer wall thickening dynamics with epicardial echocardiography. Circulation (1986) 1.21
Dissociation between regional myocardial dysfunction and ECG changes during ischemia in the conscious dog. Circulation (1980) 1.21
Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation (2000) 1.20
Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. J Natl Cancer Inst (1996) 1.19